Am­gen backs a fresh raise for AI play­er GNS Health­care; SQZ names Agar­w­al as new CMO

⇨ Am­gen Ven­tures and Alexan­dria Re­al Es­tate Eq­ui­ties have chipped in a fresh $6 mil­lion to back GNS Health­care, which has been de­vel­op­ing plat­form ma­chine learn­ing tech aimed at match­ing the right drug for a par­tic­u­lar pa­tient. “We are wit­ness­ing an ac­cel­er­a­tion in the use of ar­ti­fi­cial in­tel­li­gence and ma­chine learn­ing across all in­dus­tries with GNS lead­ing the way in the life sci­ences and health­care in­dus­tries with da­ta from tens of mil­lions of lives be­ing processed by our plat­forms,” not­ed CEO Col­in Hill.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER